Clinical Trial Update: Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating how the immune system affects response to COVID-19 vaccination in allogeneic stem cell recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019
• Hematopoietic Neoplasms

Snippet

Sponsor: University of Liege | Conditions: Coronavirus Disease 2019 (Covid19), Hematopoietic Neoplasms | Phase 3 | Status: UNKNOWN